D Orazio & Associates Inc. increased its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 4.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,982 shares of the company’s stock after acquiring an additional 120 shares during the quarter. D Orazio & Associates Inc.’s holdings in Colgate-Palmolive were worth $271,000 as of its most recent SEC filing.
A number of other large investors have also added to or reduced their stakes in the business. Kingsview Wealth Management LLC raised its position in shares of Colgate-Palmolive by 133.9% in the fourth quarter. Kingsview Wealth Management LLC now owns 36,120 shares of the company’s stock valued at $3,284,000 after purchasing an additional 20,676 shares during the period. Apollon Wealth Management LLC grew its stake in Colgate-Palmolive by 12.2% in the 4th quarter. Apollon Wealth Management LLC now owns 25,317 shares of the company’s stock valued at $2,302,000 after buying an additional 2,746 shares during the last quarter. Vest Financial LLC raised its holdings in Colgate-Palmolive by 13.9% in the 4th quarter. Vest Financial LLC now owns 575,181 shares of the company’s stock valued at $52,290,000 after acquiring an additional 69,982 shares during the period. Conning Inc. lifted its position in Colgate-Palmolive by 13.1% during the fourth quarter. Conning Inc. now owns 391,017 shares of the company’s stock worth $35,547,000 after acquiring an additional 45,281 shares during the last quarter. Finally, Platform Technology Partners boosted its holdings in shares of Colgate-Palmolive by 2.8% during the fourth quarter. Platform Technology Partners now owns 15,851 shares of the company’s stock worth $1,441,000 after acquiring an additional 432 shares during the period. Institutional investors own 80.41% of the company’s stock.
Analysts Set New Price Targets
A number of research analysts have commented on the company. UBS Group decreased their price objective on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a report on Monday, February 3rd. Morgan Stanley lowered their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. Stifel Nicolaus cut their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. Raymond James reaffirmed an “outperform” rating and set a $105.00 target price (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Finally, JPMorgan Chase & Co. cut their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. One analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $101.16.
Colgate-Palmolive Trading Up 1.3 %
Shares of CL stock opened at $86.81 on Friday. Colgate-Palmolive has a twelve month low of $82.68 and a twelve month high of $109.30. The stock’s fifty day simple moving average is $90.56 and its 200 day simple moving average is $96.84. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. The firm has a market capitalization of $70.93 billion, a P/E ratio of 24.66, a P/E/G ratio of 3.61 and a beta of 0.44.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the company earned $0.87 EPS. As a group, sell-side analysts predict that Colgate-Palmolive will post 3.74 EPS for the current fiscal year.
Colgate-Palmolive Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.30%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- 3 REITs to Buy and Hold for the Long Term
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- 3 Ways To Invest In Coffee, Other Than Drinking It
- MarketBeat Week in Review – 02/03 – 02/07
- 3 Healthcare Dividend Stocks to Buy
- Meta Platforms Continues to Prove Why It’s a Premier Play on AI
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.